Samsung Peptide to launch takeover bid for Swiss PolyPeptide
31/08/2026 06:12
Samsung Peptide to launch takeover bid for Swiss PolyPeptide Aug 31 (Reuters) - Samsung Peptide is launching a takeover offer for Swiss contract drugmaker PolyPeptide Group PPGN.S, the unit of Samsung Biologics 207940.KS said in an offer prospectus on Monday.
It will offer 44.31 Swiss francs ($54.78) per registered PolyPeptide share, with the offer period set to run from September 15 to October 12.
($1 = 0.8089 Swiss francs)
(Reporting by Tristan Veyet in Gdansk, editing by Milla Nissi-Prussak)
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)